Adverum Biotechnologies, Inc. (ADVM)
USD 4.81
(-8.03%)
USD 4.81
(-8.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -91.32 Million | -108.09 Million | -107.83 Million | -79.29 Million | -49.17 Million | -53.96 Million |
| Net Income | -117.16 Million | -154.53 Million | -145.54 Million | -117.5 Million | -64.48 Million | -72.62 Million |
| Depreciation & Amortization | 5.64 Million | 6.52 Million | 4.64 Million | 4.15 Million | 1.57 Million | 1.75 Million |
| Deferred income taxes | 369 Thousand | - | 3.83 Million | 863 Thousand | -1.27 Million | -1.25 Million |
| Stock-based compensation | 17.56 Million | 20.07 Million | 25.19 Million | 20.39 Million | 9.89 Million | 13.43 Million |
| Change in working capital | -8.31 Million | 19.88 Million | 4.06 Million | 12.72 Million | 5.05 Million | -1.62 Million |
| Other non-cash items | 10.57 Million | -51 Thousand | -25 Thousand | 75 Thousand | 58 Thousand | 6.35 Million |
| Investing Cash Flow | 96.87 Million | 141.72 Million | 78.7 Million | -280.16 Million | -68.07 Million | 69.44 Million |
| Investments in PPE | -808 Thousand | -11.81 Million | -15.12 Million | -11.84 Million | -19.24 Million | -809 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -36.71 Million | -104.36 Million | -407.51 Million | -570.38 Million | -197.34 Million | -78.72 Million |
| Sales/Maturities of investments | 134.4 Million | 257.89 Million | 501.34 Million | 302.06 Million | 148.51 Million | 148.97 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 489 Thousand | 607 Thousand | 2.39 Million | 355.98 Million | 28.19 Million | 69.94 Million |
| Debt repayment | - | -13.6 Million | -240 Thousand | -61 Thousand | -112 Thousand | -175 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 489 Thousand | 3000.00 | 2.63 Million | 344.3 Million | 25.88 Million | 70.18 Million |
| Other Financing Activities | -420 Thousand | 14.21 Million | 712 Thousand | 11.74 Million | 2.41 Million | -63 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -369 Thousand | 845 Thousand | -1.61 Million | 1.58 Million | -650 Thousand | -67 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.94 Million | 19.04 Million | 5.67 Million | 11.14 Million | 5.7 Million | -1.55 Million |
| Cash at beginning of period | 68.43 Million | 36.69 Million | 63.42 Million | 66.89 Million | 155.94 Million | 70.51 Million |
| Cash at end of period | 75 Million | 70.93 Million | 36.69 Million | 63.42 Million | 66.89 Million | 155.94 Million |
| Capital Expenditure | -808 Thousand | -11.81 Million | -15.12 Million | -11.84 Million | -19.24 Million | -809 Thousand |
| Effect of forex changes on cash | 527 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | 6.56 Million | 34.23 Million | -26.72 Million | -3.47 Million | -89.05 Million | 85.42 Million |
| Free Cash Flow | -92.13 Million | -119.9 Million | -122.95 Million | -91.13 Million | -68.41 Million | -54.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -27.13 Million | -18.47 Million | -24.78 Million | -117.16 Million | -23.71 Million | -32.88 Million |
| Depreciation & Amortization | 890 Thousand | 956 Thousand | 997 Thousand | 5.64 Million | 1 Million | 1.5 Million |
| Deferred income taxes | - | - | - | 369 Thousand | -6.47 Million | -75 Thousand |
| Stock-based compensation | 2.96 Million | 3.94 Million | 4.16 Million | 17.56 Million | 4.14 Million | 4.38 Million |
| Change in working capital | 10.13 Million | -6.36 Million | -3.77 Million | -8.31 Million | -3.67 Million | -2.43 Million |
| Other non-cash items | -7.97 Million | 5.71 Million | 6.66 Million | 10.57 Million | 7.3 Million | 5.57 Million |
| Investing Cash Flow | -13.34 Million | -2.32 Million | -22.02 Million | 96.87 Million | -9.87 Million | 18.19 Million |
| Investments in PPE | -221 Thousand | -16 Thousand | -90 Thousand | -808 Thousand | -192 Thousand | -495 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -33.32 Million | -22.51 Million | -26.93 Million | -36.71 Million | -16.48 Million | - |
| Sales/Maturities of investments | 20.2 Million | 20.2 Million | 5 Million | 134.4 Million | 6.8 Million | 18.69 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -116 Thousand | 119.88 Million | 489 Thousand | 242 Thousand | -105 Thousand |
| Debt repayment | - | - | - | - | -2.34 Million | -725 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -403 Thousand | -116 Thousand | 119.88 Million | 489 Thousand | 242 Thousand | 1000.00 |
| Other Financing Activities | - | 264 Thousand | 139 Thousand | -420 Thousand | -76 Thousand | 619 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 298 Thousand | 236 Thousand | -347 Thousand | -369 Thousand | -307 Thousand | 882 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.02 Million | -6.59 Million | -3.42 Million | -7.94 Million | -3.37 Million | -3.31 Million |
| Cash at beginning of period | 127.32 Million | 149.6 Million | 75 Million | 68.43 Million | 105.36 Million | 113.83 Million |
| Cash at end of period | 94.82 Million | 127.32 Million | 149.6 Million | 75 Million | 75 Million | 108.01 Million |
| Capital Expenditure | -221 Thousand | -16 Thousand | -90 Thousand | -808 Thousand | -192 Thousand | -495 Thousand |
| Effect of forex changes on cash | - | - | - | 527 Thousand | 674 Thousand | - |
| Net cash flow / Change in cash | -32.49 Million | -22.28 Million | 74.6 Million | 6.56 Million | -30.36 Million | -5.82 Million |
| Free Cash Flow | -21.34 Million | -19.86 Million | -23.33 Million | -92.13 Million | -21.59 Million | -24.4 Million |
AFMD
8225
MITQ
ASND
0859
LLFICL